Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$2.9 million.

  • Lemaitre Vascular's Cash from Financing Activities rose 628.97% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.1 million, marking a year-over-year increase of 186720.14%. This contributed to the annual value of $158.1 million for FY2024, which is 231710.84% up from last year.
  • Per Lemaitre Vascular's latest filing, its Cash from Financing Activities stood at -$2.9 million for Q3 2025, which was up 628.97% from -$2.8 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Cash from Financing Activities registered a high of $164.1 million during Q4 2024, and its lowest value of -$10.5 million during Q2 2021.
  • Over the past 5 years, Lemaitre Vascular's median Cash from Financing Activities value was -$2.6 million (recorded in 2022), while the average stood at $7.6 million.
  • In the last 5 years, Lemaitre Vascular's Cash from Financing Activities skyrocketed by 620874.91% in 2024 and then plummeted by 1353333.33% in 2025.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Cash from Financing Activities stood at -$1.2 million in 2021, then crashed by 83.09% to -$2.1 million in 2022, then decreased by 26.58% to -$2.7 million in 2023, then surged by 6208.75% to $164.1 million in 2024, then plummeted by 101.8% to -$2.9 million in 2025.
  • Its Cash from Financing Activities stands at -$2.9 million for Q3 2025, versus -$2.8 million for Q2 2025 and -$5.2 million for Q1 2025.